Search for new lung cancer biomarkers using 13C-labeled glucose

Phase 1

• Conditions: Resectable primary lung cancer; primary lung cancer

• Registration Number: JPRN-jRCTs051200038
• Lead Sponsor: Yoshida Masaru

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-07-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

(1) Patients who are at least 20 years old and under 80 years old at the time of obtaining consent
(2) PET-positive primary lung cancer patients who can be surgically resected
(3) Patients who have given their informed consent to participate in this clinical study

Exclusion Criteria

(1) Patients with other cancers
(2) Other patients judged inappropriate by the person in charge of this clinical study

Study & Design

• Study Type: Interventional
• Study Design: Not specified